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RESUMO – Nos últimos anos, os sensores de glicose FreeStyle Libre® têm sido associados a inúmeros casos de dermatite de con-
tato alérgica. O alérgenio responsável pela maioria destes casos é o acrilato de isobornilo, uma substância presente no sensor 
que migra através adesivo, atingindo assim a pele. A leucoderma adquirida pode surgir em áreas previamente afetada por uma 
dermatite de contato alérgica, tendo sido descrita em associação a vários dispositivos médicos com adesivos. No entanto, até ao 
momento, foi descrito apenas um caso de leucoderma induzida por sensibilização de contato ao FreeStyle Libre®. 
Descrevemos o caso de uma mulher de 41 anos com diabetes mellitus tipo 1, que desenvolveu leucoderma em associação a uma 
dermatite de contato alérgica a este sensor de glicose.
PALAVRAS-CHAVE – Acrilatos/efeitos adversos; Automonitorização da Glicemia; Dermatite de Contato Alérgica/etiologia; Hipo-
pigmentação/induzida quimicatmente.
Acquired Leukoderma in a Patient with Allergic 
Contact Dermatitis to FreeStyle Libre®  
ABSTRACT – In the past few years, the glucose sensor FreeStyle Libre® has been associated with several cases of allergic contact 
dermatitis. The allergen responsible for most of these cases is isobornyl acrylate, a substance present within the sensor that migrates 
through the adhesive, thereby reaching the skin. Acquired leukoderma, which may occur in an area previously affected by allergic 
contact dermatitis, has been described in several medical devices with adhesives. However, until the present, only one case of leu-
koderma induced by allergic contact dermatitis to FreeStyle Libre® has been described. 
We report the case of a 41-year-old woman with diabetes mellitus type 1, who developed leukoderma in association with allergic 
contact dermatitis to this glucose sensor.
KEYWORDS – Acrylates/adverse effects; Blood Glucose Self-Monitoring; Dermatitis, Allergic Contact/etiology; Hypopigmentation/
chemically induced.
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INTRODUCTION
Allergic contact dermatitis (ACD) to the glucose sensor 
FreeStyle Libre® has been increasingly recognized in the 
past few years. The allergen responsible for most cases 
is isobornyl acrylate (IBOA; CAS 5888-33-5), a substan-
ce present within the sensor that migrates through the 
adhesive, thereby reaching the skin.1 Herein we report a 
case of leukoderma induced by FreeStyle Libre®, a rare 
phenomenon occurring along with ACD to this medical 
device.
CASE REPORT
A 41-year-old woman with type 1 diabetes mellitus was 
referred to our department due to suspicion of contact der-
matitis to the glucose sensor FreeStyle Libre®, which she had 
been using for 6 months. Besides the dermatitis itself, the 
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patient also presented several hypopigmented macules and 
patches on the outer side of both arms, corresponding to 
the areas where the sensor had been applied (Fig.1A). She 
denied any personal or familiar history of vitiligo or atopy, 
and there were no similar lesions in the rest of the skin. She 
had not used other glucose sensors or insulin pumps and 
she also denied application of corticosteroids or other de-
pigmenting agents. 
Patch testing was performed with the Portuguese baseline 
series, acrylates series and plastic & glues series (Chemo-
technique Diagnostics, Vellinge, Sweden), and also with a 
piece of the adhesive patch of the glucose sensor “as is”, with 
methylhydroquinone 1.0% in pet., hydroquinone monoben-
zylether 1.0% pet. and with IBOA (purchased from Sigma-
-Aldrich and diluted 0.1% in pet. by the hospital pharmacy). 
Patch tests were performed on the upper back using IQ Ultra 
test chambers (Chemotechnique Diagnostics). Readings were 
performed on day 2 (D2) and D4, and patch test reactions 
were classified according to ESCD criteria.2 A biopsy of one 
of the hypopigmented areas was concurrently undertaken.
Positive reactions on patch tests were observed only for 
IBOA (++), with no reaction to the fragment of the tape 
of the glucose sensor (Fig. 1B). Histopathology of a hypo-
pigmented area showed a complete absence of epidermal 
melanocytes (Fig. 2A), which was confirmed by Fontana 
Masson staining (Fig. 2B).
The patient stopped using the sensor due to the cuta-
neous side effects, with a significant impact both in quality of 
life and in glycemic control. After 6 months of follow-up, she 
remains clinically stable, with no new lesions and awaiting 
transition to a new glucose sensor.
DISCUSSION
ACD to medical devices, including FreeStyle Libre®, is an 
increasingly recognized problem, posing a great challenge 
not only to patients suffering from this condition but also to 
clinicians dealing with them.3 Nonetheless, to our knowledge, 
only one case of acquired leukoderma following sensitization 
to FreeStyle Libre® has been reported in the literature.4
Acquired leukoderma may occur in an area previously 
affected by ACD, and has been described in several medical 
devices with adhesives.5 Regarding FreeStyle Libre®, IBOA 
does not seem to be the culprit substance, as it is not a 
recognized depigmenting agent.1 Moreover, the occurrence 
of leukoderma along with ACD to FreeStyle Libre® is rare, 
arising the suspicion for other explanation beyond IBOA. In 
fact, it is hypothized that hydroquinone monomethyl ether 
(HMME) may be the responsible for this reaction.4 HMME is 
a known depigmenting agent, and has even been responsi-
ble for cases of occupational leukoderma.6 In this scenario, 
it is thought that HMME may have a direct toxic effect on me-
lanocytes, potentially resulting in subclinical inflammation 
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Figuras 1 - Leukoderma after ACD to the glucose sensor FreeStyle Libre A; (A) – clinical picture showing hypopigmented macules and patches on 




via melanocyte destruction.4 This explains the histopatholo-
gical findings in our patient, notably the absence of epider-
mal melanocytes.
Actually, HMME has been identified along with the IBOA 
in the sensor, where it acts as an inhibitor to prevent inad-
vertent IBOA polymerization. It is known that IBOA is not 
present in the adhesive part of FreeStyle Libre®; however, 
it originates from the plastic material of the sensor itself 
and subsequently diffuses through the plaster to the skin, a 
phenomenon probably added by occlusion and sweating.7-9 
Therefore, it is assumed that, in some instances, HMME may 
also migrate through the adhesive along with IBOA, resul-
ting in a phenomenon of ACD with associated leukoderma, 
as in our patient.
Although rare, acquired leukoderma following ACD to 
FreeStyle Libre® can occur. Therefore, clinicians dealing with 
these patients should be alert to this possibility.
Acknowledgment
The authors would like to thank Dr. Vasco Ribeiro for 
the collaboration in the acquisition and preparation of the 
allergen IBOA.
Conflitos de interesse: Os autores declaram a inexistência de 
conflitos de interesse na realização do presente trabalho. 
Fontes de financiamento: Não existiram fontes externas de 
financiamento para a realização deste artigo. 
Confidencialidade dos dados: Os autores declaram ter segui-
do os protocolos da sua instituição acerca da publicação dos 
dados de doentes.
Consentimento: Consentimento do doente para publicação 
obtido. 
Proveniência e revisão por pares: Não comissionado; revisão 
externa por pares.
Conflicts of interest: The authors have no conflicts of interest 
to declare. 
Financing support: This work has not received any contribution, 
grant or scholarship. 
Confidentiality of data: The authors declare that they have 
followed the protocols of their work center on the publication 
of data from patients.
Patient Consent: Consent for publication was obtained. 










1. Herman A, Aerts O, Baeck M, Bruze M, Block C De, 
Goossens A, et al. Allergic contact dermatitis caused by 
isobornyl acrylate in Freestyle ® Libre, a newly introdu-
ced glucose sensor. Contact Dermatitis. 2017;77:367-
73. doi: 10.1111/cod.12866
2. Johansen JD, Aalto-korte K, Agner T, Andersen KE, Bir-
cher A, Bruze M, et al. European Society of Contact 
Dermatitis guideline for diagnostic patch testing – re-
commendations on best practice. Contact Dermatitis. 
2015;73:195-221. doi: 10.1111/cod.12432.
3. Hyry HSI, Liippo JP, Virtanen HM. Allergic contact der-
matitis caused by glucose sensors in type 1 diabe-
tes patients. Contact Dermatitis. 2019;81:161-6. doi: 
10.1111/cod.13337.
4. Herman A, Montjoye L De, Marot L, Baeck M. Induc-
tion of leukoderma following allergic contact dermatitis 
to FreeStyle Libre. Contact Dermatitis. 2019;81:456-8. 
Revista SPDV 78(4) 2020; Leucodermia adquirida num doente com dermatite de contacto alérgica ao FreeStyle Libre®; Queirós CS, Alexandre MI, Garrido PM, 
Soares de Almeida L, Correia T, Filipe P.
Figura 2 - Histological examination of the hypopigmented areas; (A) – Hematoxylin and eosin staining demonstrating an absence of epidermal 





5. Gordon S, LaTorre A, Witman P. Persistent pedia-
tric contact leukoderma after exposure to butter-
fly electrocardiogram back pad: a report of three 
cases. Pediatr Dermatol. 2013;30:169–71. doi: 
10.1111/j.1525-1470.2012.01872.x.
6. Chivers C. Two cases of occupational leucoderma 
following contact with hydroquinone monomethyl ether. 
Br J Ind Med. 1972;29:105-7. 
7. Kamann S, Aerts O, Heinemann L. Further eviden-
ce of severe allergic contact dermatitis from isobornyl 
acrylate while using a continuous glucose monitoring 
system. J Diabetes Sci Technol. 2018;12:630–-3. doi: 
10.1177/1932296818762946.
8. Kamann S, Oppel E, Liu F, Reichl F, Heinemann L, Hogg 
C. Evaluation of isobornyl acrylate content in medical 
devices for diabetes treatment. Diabetes Technol Ther. 
2019;21:533–7. doi: 10.1089/dia.2019.0163.
9. Herman A, Darrigade A, de Montjoye L, Baeck M. Con-
tact dermatitis caused by glucose sensors in diabetic 
children. Contact Dermatitis. 2020;82:105–11. doi: 
10.1111/cod.13429.
Revista SPDV 78(4) 2020; Leucodermia adquirida num doente com dermatite de contacto alérgica ao FreeStyle Libre®; Queirós CS, Alexandre MI, Garrido PM, 
Soares de Almeida L, Correia T, Filipe P.
